Daily non-political popular news in brief.

New findings on emerging contaminants

02-16-2008 · EurekAlert!

Substances that we use everyday are turning up in our lakes, rivers and ocean, where they can impact aquatic life and possibly ourselves. At a press conference at the 2008 Annual Meeting of the American Association for the Advancement of Science in Boston, a panel of researchers will discuss how these chemicals are affecting aquatic environments and may be coming back to haunt us in unanticipated ways.

Keywords: findings, emerging, contaminants, finding, contaminant

« Previous | Next »

Similar news on "New findings on emerging contaminants":

Advancing how computers and electronics work
03-19-2007 · EurekAlert!
Researchers have made an important advance in the emerging field of 'spintronics' that may one day usher in a new generation of smaller, smarter, faster computers, sensors and other devices, according to findings reported in today's issue of the journal Nature Nanotechnology.
Similar news · Read more »
How insulin-producing cells develop -- new finding could help fight against diabetes
05-17-2007 · EurekAlert!
A key aspect of how embryos create the cells which secrete insulin is revealed in a new study published tomorrow in the Journal of Biological Chemistry. The researchers hope that their findings will enable the development of new therapies for diabetes, a condition caused by insufficient levels of insulin. The research reveals that glucose plays a key role in enabling healthy beta cells, which secrete insulin, to develop in the pancreas of an embryo.
Similar news · Read more »
High degree of resistance to antibiotics in Arctic birds
01-11-2008 · EurekAlert!
In the latest issue of the journal Emerging Infectious Diseases, Swedish researchers report that birds captured in the hyperboreal tundra, in connection with the tundra expedition "Beringia 2005," were carriers of antibiotics-resistant bacteria. These findings indicate that resistance to antibiotics has spread into nature, which is an alarming prospect for future health care.
Similar news · Read more »
e-Science points to pollution solutions
08-21-2007 · EurekAlert!
Results from a UK e-Science project are helping to solve two pressing environmental problems. One finding could help to avoid arsenic contamination of drinking water extracted from man-made wells. Another could lead to improved methods of removing the now-banned industrial chemical, dioxin, from soil. The results were obtained using e-Science techniques and grid computing to simulate all the possible interactions between these contaminants and rock or soil.
Similar news · Read more »
2 different neural pathways regulate loss and regain of consciousness during general anesthesia
01-11-2008 · EurekAlert!
University of Pennsylvania School of Medicine researchers have answered long-running questions about the way that anesthetics act on the body, by showing that the cellular pathway for emerging from anesthesia is different from the one that drugs take to put patients to sleep during operations. The findings will be published this week in Proceedings of the National Academy of Sciences.
Similar news · Read more »
Einstein researchers find that a commonly found contaminant may harm nursing infants
12-03-2007 · EurekAlert!
Scientists at the Albert Einstein College of Medicine of Yeshiva University have shown that perchlorate -- an industrial pollutant linked to thyroid ailments -- is actively concentrated in breast milk. Their findings suggest that perchlorate contamination of drinking water may pose a greater health risk than previously realized. The study appears in the Dec. 3-7 advance online issue of the Proceedings of the National Academy of Sciences.
Similar news · Read more »
Researchers identify genetic mutation that may alter tumor cell proliferation
07-04-2007 · EurekAlert!
Researchers from Eli Lilly & Company and the Phoenix-based Translational Genomics Research Institute today announced finding a novel recurring mutation of the gene AKT1 in breast, colorectal and ovarian cancers. The altered form of AKT1 appears to cause tumor cell proliferation and may play a role in making cells resistant to certain types of therapies. The findings are reported in an advance online publication of the journal Nature.
Similar news · Read more »
Hearing changes how we perceive gender
10-24-2007 · EurekAlert!
Think about the confused feelings that occur when you meet someone whose tone of voice doesn't seem to quite fit with his or her gender. Neuroscientists from Northwestern University focus on the brain's processing of such sensory information in a new study that concludes that hearing fundamentally changes visual experience. The researchers weigh in with findings that contribute to provocative evidence about multisensory processing of our world that has been emerging in recent years.
Similar news · Read more »
Microbes start immune response by sneaking inside cells
04-13-2007 · EurekAlert!
Bacteria that insert themselves inside key front-line immune cells in mice can trigger a strong immune response, according to a new University of Michigan study published online in Immunity. The findings add to an emerging new picture of the immune response that points the way to more effective vaccines and more precisely targeted drugs for autoimmune diseases such as rheumatoid arthritis.
Similar news · Read more »
Advance in understanding of blood pressure gene could lead to new treatments
02-04-2007 · EurekAlert!
Research by scientists at UCL (University College London) has clearly demonstrated for the first time the structure and function of a gene crucial to the regulation of blood pressure. The discovery could be important in the search for new treatments for illnesses such as heart disease, the UK's biggest killer. In a paper published online today in Nature Medicine, the team, led by Professor Patrick Vallance and Dr James Leiper, UCL Department of Medicine, reveal the role of the human gene dimethylarginine dimethylaminohydrolase (DDAH), showing that loss of DDAH activity disrupts nitric oxide (NO) production. NO is critical in the regulation of blood pressure, nervous system functions and the immune system. The role of DDAH is to break down modified amino acids (Asymmetric dimethylarginine (ADMA) and monomethyl arginine (L-NMMA)) that are produced by the body and have been shown to inhibit NO synthase. These molecules accumulate in various disease states including diabetes, renal failure and pulmonary and systemic hypertension, and their concentration in plasma (the fluid component of blood) is strongly predicative of cardiovascular disease and death. In a healthy human body, the majority of ADMA is eliminated through active metabolism by DDAH. Scientists have hypothesised that if DDAH function is impaired, NO production is reduced, and that this could be an important feature of increased cardiovascular risk. To examine this pathway in more detail, the researchers deleted the DDAH gene in mice. These mice went on to develop hypertension, or high blood pressure. They also designed specific inhibitors (small molecules) which bind to the active site of human DDAH. These small molecule inhibitors also induced hypertension in mice, confirming the importance of DDAH in the regulation of blood pressure. Dr Leiper, UCL Medicine, said: “These genetic and chemical approaches to disrupt DDAH showed remarkably consistent results, and provide compelling evidence that loss of DDAH function increases the concentration of ADMA and thereby disrupts vascular NO signalling. “There has been considerable scientific interest in this pathway and the role of ADMA as a novel risk factor, but so far there's been little evidence to support the idea that it's a cause of disease, rather than just a marker. Genes and their pathways are crucial to our understanding of cardiovascular disease and a better understanding of DDAH-1 could lead to important new treatments. “It could help us to establish if genetic variation predisposes certain people to these diseases, or whether environmental factors exert some of their effects through modulation of DDAH activity. “Our research also shows that this pathway could be harnessed therapeutically to limit production of NO in certain situations where too much nitric oxide is a bad thing; for example, hypotension and septic shock. These are some of the biggest problems in intensive care medicine and there is a huge unmet need for drug treatments.” The study, which was carried out at UCL's Rayne Institute, was funded by grants from the British Heart Foundation, the Wellcome Trust and the Medical Research Council. Professor Jeremy Pearson, Associate Medical Director of the British Heart Foundation, said: "The unexpected finding in the 1980s that a simple gas, nitric oxide (NO), is made by cells in the blood vessel wall and is a powerful control of blood vessel relaxation led to the award of the Nobel Prize in 1998 to its discoverers. "More recently, there has been increasing evidence that impairment of NO production is likely to be an important factor in the development of heart and circulatory disease, but the mechanisms responsible are not fully understood. "This study suggests for the first time that the loss of the activity of the enzyme DDAH-1 leads to reduced NO production and may cause heart and circulatory disease. These findings are likely to be important in the search for new ways to optimise the health of our blood vessels." ### Notes for Editors 1. For more information, please contact Ruth Metcalfe in the UCL Media Relations Office on tel: +44 (0)20 7679 9739, mobile: +44 (0)7990 675 947, out of hours: +44 (0)7917 271 364, e-mail: r.metcalfe@ucl.ac.uk2. 'Disruption of methylarginine metabolism impairs vascular homeostasis' is published in the February issue of the journal Nature Medicine. Advance online publication is embargoed to 18.00 GMT (13.00 US Eastern) Sunday 4 February 2007. Journalists can obtain copies of the paper by contacting the UCL Media Relations Office.3. The study was funded by the British Heart Foundation, the Wellcome Trust and the Medical Research Council. About UCL Founded in 1826, UCL was the first English university established after Oxford and Cambridge, the first to admit students regardless of race, class, religion or gender, and the first to provide systematic teaching of law, architecture and medicine. In the government's most recent Research Assessment Exercise, 59 UCL departments achieved top ratings of 5* and 5, indicating research quality of international excellence. UCL is the fourth-ranked UK university in the 2006 league table of the top 500 world universities produced by the Shanghai Jiao Tong University. UCL alumni include Mahatma Gandhi (Laws 1889, Indian political and spiritual leader); Jonathan Dimbleby (Philosophy 1969, writer and television presenter); Junichiro Koizumi (Economics 1969, Prime Minister of Japan); Lord Woolf (Laws 1954, Lord Chief Justice of England & Wales); Alexander Graham Bell (Phonetics 1860s, inventor of the telephone), and members of the band Coldplay.
Similar news · Read more »